Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorChang Gung Memorial Hospital
About this trial
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Eligibility criteria
Qualifiers
Age ≥20
Pathology:Squamous cell carcinoma
Need CCRT treatment
ECOG PS<2
Disqualifiers
ECOG PS≥2
Unable to tolerate basic exercise, or CCRT treatment
Mental illness or any medical illness or concurrent illness that may be aggravated by exercise training or unmanageable
Any medical condition that unsuitable for exercise
Trial design
Treatments tested in this trial
- HIIT & Record of physical activities at home.
- HIIT only
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov